chrX-153982391-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003492.3(TMEM187):c.329G>A(p.Arg110His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000226 in 1,197,047 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 15 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003492.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMEM187 | NM_003492.3 | c.329G>A | p.Arg110His | missense_variant | 2/2 | ENST00000369982.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMEM187 | ENST00000369982.5 | c.329G>A | p.Arg110His | missense_variant | 2/2 | 1 | NM_003492.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000352 AC: 4AN: 113572Hom.: 0 Cov.: 26 AF XY: 0.0000840 AC XY: 3AN XY: 35728
GnomAD3 exomes AF: 0.0000386 AC: 6AN: 155428Hom.: 0 AF XY: 0.0000606 AC XY: 3AN XY: 49492
GnomAD4 exome AF: 0.0000212 AC: 23AN: 1083475Hom.: 0 Cov.: 33 AF XY: 0.0000339 AC XY: 12AN XY: 354251
GnomAD4 genome AF: 0.0000352 AC: 4AN: 113572Hom.: 0 Cov.: 26 AF XY: 0.0000840 AC XY: 3AN XY: 35728
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2022 | The c.329G>A (p.R110H) alteration is located in exon 2 (coding exon 1) of the TMEM187 gene. This alteration results from a G to A substitution at nucleotide position 329, causing the arginine (R) at amino acid position 110 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at